Featured
Read our handpicked blogs, curated for you.
|
The enterprise landscape for conversational AI is currently defined by a widening value gap. While over 70% of white-…
|
The current enterprise landscape for RPA technology shows diminishing returns. While 97% of executives report deploying…
|
Most enterprises running robotic process automation for enterprises have the same story. Early pilots impressed…
Recent releases
|
The Compliance Advantage Turning UCPMP into a Competitive Edge
In most boardrooms, UCPMP is still seen as a regulatory headache. Something for compliance teams to manage, while marketing quietly complains about delays and restrictions. But this view is outdated…
|
Pharma CRM Blind Spots: Why HCP Journeys Need More Than a Rep Log
Pharma CRM has long been the backbone of sales operations in Indian pharma. For years, it has served as the digital logbook of rep interactions, who visited which doctor, when, and with what message…
|
Pharma Content Engines Why PowerPoint and Agencies Are No Longer Enough
Every pharma CMO knows the routine. A brand team needs new content. An agency is briefed, a PowerPoint deck is created, and then the MLR process drags for weeks. By the time it’s approved, the…
|
Next Best Action Artificial Intelligence in Pharma Separating Hype from Real Outcomes
Everywhere you turn, someone is pitching artificial intelligence in pharma as the future. Vendors promise predictive insights, automated engagement, and “next best action” recommendations that will…
